Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI

<p>Abstract</p> <p>Background</p> <p>MANTICORE 101 - Breast (Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research) is a randomized trial to determine if conventional heart failure pharmacotherapy (angiotensin converting enzyme inhibitor or beta-...

Full description

Bibliographic Details
Main Authors: Ezekowitz Justin, Thompson Richard B, Mackey John R, Haykowsky Mark, Pituskin Edith, Koshman Sheri, Oudit Gavin, Chow Kelvin, Pagano Joseph J, Paterson Ian
Format: Article
Language:English
Published: BMC 2011-07-01
Series:BMC Cancer
Subjects:
Cardiotoxicity
Heart failure
Cardiac remodeling
Trastuzumab
Breast cancer
Online Access:http://www.biomedcentral.com/1471-2407/11/318

Internet

http://www.biomedcentral.com/1471-2407/11/318

Similar Items